Aardvark Therapeutics

#Aardvark Therapeutics #Biotechnology #Drug discovery #Obesity

New podcast: A new paradigm of appetite and hunger

In the In Conversation With series, a part of the free DDW podcast, DDW speaks with members of the drug discovery industry about their work and how it helps turn science into business.    In this episode, Megan Thomas is in conversation with Tien Lee, CEO… Read More

#News

#Aardvark Therapeutics #Financing #Investment #Obesity #Orphan drugs #Rare disease

Funding of $85 million secured for Prader-Willi Syndrome drug

Aardvark Therapeutics has announced an $85 million oversubscribed Series C financing. The funding will be used to complete the clinical trials required for regulatory approval of Aardvark’s lead asset, ARD-101, for the treatment of hyperphagia in patients with Prader-Willi Syndrome (PWS), as well as to demonstrate… Read More

#Business & Investment #News